High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission

Summary Preventing transmission is an important element of malaria control. However, most of the current available methods to assay for malaria transmission blocking are relatively low throughput and cannot be applied to large chemical libraries. We have developed a high-throughput and cost-effective assay, the Saponin-lysis Sexual Stage Assay (SaLSSA), for identifying small molecules with transmission-blocking capacity. SaLSSA analysis of 13,983 unique compounds uncovered that >90% of well-characterized antimalarials, including endoperoxides and 4-aminoquinolines, as well as compounds active against asexual blood stages, lost most of their killing activity when parasites developed into metabolically quiescent stage V gametocytes. On the other hand, we identified compounds with consistent low nanomolar transmission-blocking activity, some of which showed cross-reactivity against asexual blood and liver stages. The data clearly emphasize substantial physiological differences between sexual and asexual parasites and provide a tool and starting points for the discovery and development of transmission-blocking drugs.

[1]  M. Delves.  Plasmodium cell biology should inform strategies used in the development of antimalarial transmission-blocking drugs. , 2012, Future medicinal chemistry.

[2]  D. L. Klayman,et al.  2-Acetylpyridine thiosemicarbazones. 1. A new class of potential antimalarial agents. , 1979, Journal of medicinal chemistry.

[3]  R. Sinden,et al.  The effect of atovaquone (566C80) on the maturation and viability of Plasmodium falciparum gametocytes in vitro. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  K. Williamson,et al.  The Proteasome Inhibitor Epoxomicin Has Potent Plasmodium falciparum Gametocytocidal Activity , 2009, Antimicrobial Agents and Chemotherapy.

[5]  J. Vinetz,et al.  In vitro generation of Plasmodium falciparum ookinetes. , 2010, The American journal of tropical medicine and hygiene.

[6]  P. Gething,et al.  Transmission-blocking interventions eliminate malaria from laboratory populations , 2013, Nature Communications.

[7]  D. Fidock,et al.  Identification of MMV Malaria Box Inhibitors of Plasmodium falciparum Early-Stage Gametocytes Using a Luciferase-Based High-Throughput Assay , 2013, Antimicrobial Agents and Chemotherapy.

[8]  R. Sinden.  Malaria, sexual development and transmission: retrospect and prospect , 2009, Parasitology.

[9]  M. Poot,et al.  Efficacy of MitoTracker Green™ and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[10]  David W. Gray,et al.  A novel multiple-stage antimalarial agent that inhibits protein synthesis , 2015, Nature.

[11]  S. Schreiber,et al.  Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.

[12]  Leann Tilley,et al.  Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion , 2011, Proceedings of the National Academy of Sciences.

[13]  S. Mayfield,et al.  Algae-Produced Pfs25 Elicits Antibodies That Inhibit Malaria Transmission , 2012, PloS one.

[14]  R. Sinden,et al.  A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines. , 2012, International journal for parasitology.

[15]  R. Sinden.  Sexual development of malarial parasites. , 1983, Advances in parasitology.

[16]  Neil Hall,et al.  Regulation of Sexual Development of Plasmodium by Translational Repression , 2006, Science.

[17]  S. Hoffman,et al.  Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue , 2011, Proceedings of the National Academy of Sciences.

[18]  Gonzalo Colmenarejo,et al.  A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery , 2015, PloS one.

[19]  C. Rogier,et al.  Sex ratio of Plasmodium falciparum gametocytes in inhabitants of Dielmo, Senegal , 2003, Parasitology.

[20]  A. Stead,et al.  Diamidine compounds: selective uptake and targeting in Plasmodium falciparum. , 2001, Molecular pharmacology.

[21]  R. Hayward,et al.  Plasmodium falciparum phosphoenolpyruvate carboxykinase is developmentally regulated in gametocytes. , 2000, Molecular and biochemical parasitology.

[22]  M. Kirschner,et al.  Thiostrepton and Derivatives Exhibit Antimalarial and Gametocytocidal Activity by Dually Targeting Parasite Proteasome and Apicoplast , 2011, Antimicrobial Agents and Chemotherapy.

[23]  Yingyao Zhou,et al.  Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery , 2011, Science.

[24]  Stefan Wetzel,et al.  The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..

[25]  K. Williamson,et al.  Potent Plasmodium falciparum Gametocytocidal Activity of Diaminonaphthoquinones, Lead Antimalarial Chemotypes Identified in an Antimalarial Compound Screen , 2014, Antimicrobial Agents and Chemotherapy.

[26]  R. Sinden,et al.  Imaging-Based High-Throughput Screening Assay To Identify New Molecules with Transmission-Blocking Potential against Plasmodium falciparum Female Gamete Formation , 2015, Antimicrobial Agents and Chemotherapy.

[27]  Frank Schluenzen,et al.  Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin. , 2008, Molecular cell.

[28]  Robert W. Sauerwein,et al.  Targeting Plasmodium PI(4)K to eliminate malaria , 2013, Nature.

[29]  E. Winzeler,et al.  The Activities of Current Antimalarial Drugs on the Life Cycle Stages of Plasmodium: A Comparative Study with Human and Rodent Parasites , 2012, PLoS medicine.

[30]  B. Hall,et al.  A Model for Sequestration of the Transmission Stages of Plasmodium falciparum: Adhesion of Gametocyte-Infected Erythrocytes to Human Bone Marrow Cells , 2000, Infection and Immunity.

[31]  Ruili Huang,et al.  Chemical signatures and new drug targets for gametocytocidal drug development , 2014, Scientific Reports.

[32]  Peter G. Schultz,et al.  In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen , 2008, Proceedings of the National Academy of Sciences.

[33]  Leann Tilley,et al.  Soft X-ray microscopy analysis of cell volume and hemoglobin content in erythrocytes infected with asexual and sexual stages of Plasmodium falciparum. , 2012, Journal of structural biology.

[34]  L. Luzzatto.  Genetics of red cells and susceptibility to malaria. , 1979, Blood.

[35]  Bruce Russell,et al.  Spiroindolones, a Potent Compound Class for the Treatment of Malaria , 2010, Science.

[36]  Dac-Trung Nguyen,et al.  A quantitative high throughput assay for identifying gametocytocidal compounds. , 2013, Molecular and biochemical parasitology.

[37]  C. Press.  Cell host & microbe , 2007 .

[38]  M. Poot,et al.  Analysis of mitochondrial morphology and function with novel fixable fluorescent stains. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  R. Carter,et al.  Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. , 1979, Bulletin of the World Health Organization.

[40]  W. Richter,et al.  Hemolysis of human erythrocytes with saponin affects the membrane structure. , 2000, Acta histochemica.

[41]  Teun Bousema,et al.  Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs , 2010 .

[42]  M. Cassera,et al.  Antiapicoplast and Gametocytocidal Screening To Identify the Mechanisms of Action of Compounds within the Malaria Box , 2013, Antimicrobial Agents and Chemotherapy.

[43]  Organización Mundial de la Salud.  Guidelines for the treatment of malaria , 2010 .

[44]  V. Avery,et al.  Development and Optimization of a Novel 384-Well Anti-Malarial Imaging Assay Validated for High-Throughput Screening , 2012, The American journal of tropical medicine and hygiene.

[45]  V. Avery,et al.  Identification of inhibitors of Plasmodium falciparum gametocyte development , 2013, Malaria Journal.

[46]  Sivaraman Dandapani,et al.  Grand challenge commentary: Accessing new chemical space for 'undruggable' targets. , 2010, Nature chemical biology.

[47]  K. Kuhen,et al.  KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission , 2014, Antimicrobial Agents and Chemotherapy.

[48]  N. Lang-Unnasch,et al.  Metabolic changes of the malaria parasite during the transition from the human to the mosquito host. , 1998, Annual review of microbiology.

[49]  R. Sinden,et al.  A Male and Female Gametocyte Functional Viability Assay To Identify Biologically Relevant Malaria Transmission-Blocking Drugs , 2014, Antimicrobial Agents and Chemotherapy.

[50]  Silvia Parapini,et al.  A Plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection. , 2013, The Journal of antimicrobial chemotherapy.

[51]  T. Dandekar,et al.  Interactions of Methylene Blue with Human Disulfide Reductases and Their Orthologues from Plasmodium falciparum , 2007, Antimicrobial Agents and Chemotherapy.

[52]  C. Happi,et al.  Plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in Nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies. , 2011, Memorias do Instituto Oswaldo Cruz.

[53]  Jeremy N. Burrows,et al.  The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases , 2013, PloS one.

[54]  D. Mancama,et al.  Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination , 2015, Malaria Journal.

[55]  T. Bousema,et al.  A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs. , 2015, The Journal of antimicrobial chemotherapy.

[56]  S. Sharp,et al.  Improved synchronous production of Plasmodium falciparum gametocytes in vitro. , 2007, Molecular and biochemical parasitology.

[57]  T. Spicer,et al.  A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes. , 2011, Molecular and biochemical parasitology.

[58]  Hongshen Ma,et al.  (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium , 2014, Proceedings of the National Academy of Sciences.

[59]  R. Sinden.  Gametocytogenesis of Plasmodium falciparum in vitro: ultrastructural observations on the lethal action of chloroquine. , 1982, Annals of tropical medicine and parasitology.

[60]  T. Bousema,et al.  Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. , 2014, The Lancet. Infectious diseases.

[61]  Michael P Barrett,et al.  Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. , 2003, Trends in parasitology.